14-15 November 2018
|European Case Law Identifier:||ECLI:EP:BA:2012:T113911.20120130|
|Date of decision:||30 January 2012|
|Case number:||T 1139/11|
|IPC class:||A61K 31/4747
|Language of proceedings:||EN|
|Download and more information:||
|Title of application:||Liquid pharmaceutical formulations of palonosetron|
|Applicant name:||Helsinn Healthcare S.A.|
|Opponent name:||DR REDDYS LABORATORIES (UK) LIMITED
White, Martin Paul
Tecnimede Sociedade Tecnico-Medicinal, S.A.
|Relevant legal provisions:||
|Keywords:||Missing statement of grounds|
Summary of Facts and Submissions
I. The appeal contests the decision of the opposition division dispatched by registered letter with advice of delivery on 24 March 2011, revoking European patent No. 1 601 359.
The appellant (proprietor) filed a notice of appeal in a letter received on 24 May 2011 and paid the fee for appeal on the same day. No statement of grounds was filed.
II. In a communication dated 29 August 2011, sent by registered post, the registrar of the board informed the appellant that no statement of grounds of appeal had been filed and that it was to be expected that the appeal would be rejected as inadmissible. The appellant was invited to file observations within two months.
III. No reply was filed to said communication.
Reasons for the Decision
1. Article 108 EPC requires that a statement setting out the grounds of appeal shall be filed within four months of notification of the decision. Pursuant to Rule 101(1) EPC the appeal shall be rejected as inadmissible if it does not comply with Article 108 EPC.
2. In the present case no document was filed by the appellant which could be regarded as a statement setting out the grounds of appeal. Consequently the appeal has to be rejected as inadmissible.
For these reasons it is decided that:
The appeal is rejected as inadmissible.